Hatchtech Pty Ltd
http://hatchtech.com.au/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Hatchtech Pty Ltd
Keeping Track: US FDA Approves Siliq, Accepts Mylan/Biocon Pegfilgrastim Biosimilar
The latest drug development news and highlights from our FDA Performance Tracker.
FDA Combs Out Knotty Development Issues For Head Lice Products
Draft guidance notes special safety considerations for the treatments, which would usually be used on healthy kids.
Deals Shaping The Medical Industry, October 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical Tools – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2015.
Keeping Track: Allergan Antipsychotic Vraylar Approved; First-Line Imbruvica Claim Submitted
The latest drug development news and highlights from our FDA Performance Tracker.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice